TNF and tuberculosis: Singh and colleagues indicated the risk of serious infections is increased 30% during the treatment of anti-TNFα therapy [11], and common infections such as tuberculosis (TB), bacterial sepsis, Streptococcus pneumoniae, and Listeria monocytogenes might lead to hospitalization or death.